Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Hives on waist and chest; Itch; This non-serious case was reported by a consumer via call center representative and described the occurrence of hives in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included hypertension (has hypertension). Concomitant products included amlodipine maleate (Amlodipine). On 02-JUN-2025, the patient received the 1st dose of Shingrix. On 09-JUN-2025, 7 days after receiving Shingrix, the patient experienced hives (Verbatim: Hives on waist and chest) and pruritus (Verbatim: Itch). The patient was treated with diphenhydramine hydrochloride (Benadryl). The outcome of the hives and pruritus were resolved. It was unknown if the reporter considered the hives and pruritus to be related to Shingrix. It was unknown if the company considered the hives and pruritus to be related to Shingrix. Additional Information: GSK Receipt Date: 10-JUN-2025 The reporter was the patient. The patient received the first dose of Shingrix on Monday, 2 June 2025 from a local pharmacy. On 9 June 2025, the patient experienced hives and itch on his waist and chest. The patient took Benadryl and the hives resolved.
Hypertension (has hypertension)
AMLODIPINE